Establishing Long-Term Safety & Immunization Protocols After B-Cell Depletion Therapy

• Understanding the data needed to establish evidence-based guidelines for revaccination timing and efficacy following deep B-cell depletion
• Establishing a framework for determining the appropriate risk threshold for autoimmune patients to undergo deep B-cell depletion
• Defining long-term surveillance markers to monitor the safety of B-cell depletion therapies using longitudinal immune monitoring data

Speakers:

Heather Raymon

Senior Vice President - Research & Early Development

Artiva Bio